Plain-English translation of NCT07443475 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing electrochemotherapy, a treatment that combines an intravenous chemotherapy drug called bleomycin with controlled electric pulses applied directly to cancer tumors. The study focuses on women whose vulvar cancer has returned after previous treatment. Researchers want to see if this combination approach can shrink tumors while being safe and maintaining quality of life.
Vulvar cancer that comes back after initial surgery or treatment is difficult to manage and often requires additional surgery. This new treatment offers a potential alternative that might reduce the need for extensive surgery and its associated complications, while potentially offering better outcomes for patients.
You likely qualify if…
You likely don't qualify if…
You would receive electrochemotherapy as an outpatient procedure, which involves receiving bleomycin through an IV followed by electric pulses applied to your tumor area. Your medical team will assess how well the treatment works using imaging and clinical exams, and you'll be monitored for any side effects. You'll also complete quality-of-life surveys and pain assessments throughout the study, which lasts approximately 5 years.
AI-generated summary from trial data · Oct 12, 2026 · Not medical advice
Slovenia